Brind.

Novoheart, a subsidiary of Medera Inc., is collaborating with Mayo Clinic on mini-heart models, aligning with FDA guidelines for drug development.

2 reports, 1 independent Updated Mon 00:00

Still developing

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Novoheart, a subsidiary of Medera Inc., is collaborating with Mayo Clinic on mini-heart models, aligning with FDA guidelines for drug development.

Who's involved

What this event is mainly about

Mayo Clinic FDA

How it developed

Newest first. Tap a step to see who reported it.

Mon 00:00Novoheart expands international deployment and forms new research partnerships with IQVIA and AstraZeneca.1 source
- manilatimes.net
Jun 24Medera/Novoheart and Mayo Clinic partner on mini-heart models for drug development.

Keep exploring

The entities involved

Mayo Clinic
medical practice and medical research group based in Rochester, Minnesota, United States
- University of Minnesota Rochester is located near the Mayo Clinic campus in downtown Rochester.Fri 16:35
- Allan Swenson began his imaging career at Mayo Clinic and assumed a role at TridentCare.Thu 19:19
FDA
- Neurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.13:51
- Clene Inc. submitted an NDA to the FDA seeking accelerated approval while trading on the Nasdaq exchange.11:34

Coverage

Newest first; wire copies grouped

Mon 00:00manilatimes.net
Jun 24Unknown outlet